0001209191-22-003526.txt : 20220118 0001209191-22-003526.hdr.sgml : 20220118 20220118170932 ACCESSION NUMBER: 0001209191-22-003526 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220114 FILED AS OF DATE: 20220118 DATE AS OF CHANGE: 20220118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Menichella Daniel L CENTRAL INDEX KEY: 0001472131 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38822 FILM NUMBER: 22535896 MAIL ADDRESS: STREET 1: 79 TW ALEXANDER DRIVE STREET 2: 4101 RESEARCH COMMONS CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kaleido Biosciences, Inc. CENTRAL INDEX KEY: 0001751299 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 617-674-9000 MAIL ADDRESS: STREET 1: 18 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-14 0 0001751299 Kaleido Biosciences, Inc. KLDO 0001472131 Menichella Daniel L C/O KALEIDO BIOSCIENCES 65 HAYDEN AVENUE LEXINGTON MA 02421 1 1 0 0 Chief Executive Officer Restricted Stock Units 2022-01-14 4 A 0 70200 0.00 A Common Stock 70200 70200 D Restricted Stock Units 2022-01-14 4 A 0 250000 0.00 A Common Stock 250000 250000 D Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units shall vest 100% on April 30, 2022 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer. The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer. /s/ Daniel L. Menichella 2022-01-18